Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro, Zepbound Sales Double - Investor's Business Daily
business 2026/02/04 13:15:00

Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro, Zepbound Sales Double - Investor's Business Daily

Source:Investor's Business Daily
Author:None

While Novo Nordisk is calling for a sales downfall in 2026, Eli Lilly is more upbeat.